SG
TMO icon

Swarthmore Group’s Thermo Fisher Scientific TMO Stock Holding History

Swarthmore Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$475K Sell
875
-14,333
-94% -$7.89M 0.19% 10
2022
Q1 		$8.98M Sell
15,208
-155
-1% -$89K 2.29% 6
2021
Q4 		$10.3M Sell
15,363
-8,937
-37% -$5.58M 2.44% 7
2021
Q3 		$12.3M Hold
24,300
– – 3.17% 4
2021
Q2 		$12.3M Sell
24,300
-790
-3% -$373K 3.17% 4
2021
Q1 		$11.5M Buy
25,090
+23,041
+1,124% +$11M 3.13% 6
2020
Q4 		$954K Sell
2,049
-26,554
-93% -$12.5M 3.65% 3
2020
Q3 		$12.6M Sell
28,603
-872
-3% -$360K 3.97% 3
2020
Q2 		$10.7M Buy
29,475
+27,200
+1,196% +$9.12M 3.64% 4
2020
Q1 		$645K Sell
2,275
-31,600
-93% -$9.96M 3.42% 6
2019
Q4 		$11M Sell
33,875
-4,725
-12% -$1.43M 2.55% 4
2019
Q3 		$11.2M Sell
38,600
-950
-2% -$272K 2.78% 5
2019
Q2 		$11.6M Buy
39,550
+35,675
+921% +$9.83M 2.86% 5
2019
Q1 		$1.06M Sell
3,875
-42,575
-92% -$10.6M 4.56% 4
2018
Q4 		$10.4M Sell
46,450
-2,500
-5% -$587K 2.71% 8
2018
Q3 		$11.9M Sell
48,950
-1,050
-2% -$242K 2.68% 5
2018
Q2 		$10.4M Hold
50,000
– – 2.5% 8
2018
Q1 		$10.3M Sell
50,000
-1,450
-3% -$304K 2.46% 8
2017
Q4 		$9.77M Buy
51,450
+10,000
+24% +$1.92M 2.09% 11
2017
Q3 		$7.84M Sell
41,450
-10,250
-20% -$1.86M 1.79% 18
2017
Q2 		$9.02M Sell
51,700
-48,625
-48% -$8.17M 2.08% 19
2017
Q1 		$15.4M Sell
100,325
-4,050
-4% -$619K 2.37% 22
2016
Q4 		$14.7M Sell
104,375
-15,075
-13% -$2.22M 2.2% 20
2016
Q3 		$19M Sell
119,450
-3,350
-3% -$516K 3.64% 11
2016
Q2 		$18.1M Sell
122,800
-44,000
-26% -$6.49M 3.08% 11
2016
Q1 		$23.6M Buy
+166,800
New +$22.4M 3.61% 13

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swarthmore Group's TMO Position: Q2 2022 in Review

Swarthmore Group reduced its Thermo Fisher Scientific (TMO) stake by 94% in Q2 2022, selling an estimated $7.89M and leaving 875 shares worth $475K. The position accounts for 0.19% of the portfolio, ranked #10.

Swarthmore Group first reported a position in TMO in Q1 2016 and has held it in 26 quarters since. The position peaked at $23.6M in Q1 2016. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Swarthmore Group held 875 shares of Thermo Fisher Scientific worth $475K as of Q2 2022.
  • Swarthmore Group sold 14,333 Thermo Fisher Scientific shares in Q2 2022, an estimated $7.89M.
  • Thermo Fisher Scientific made up 0.19% of Swarthmore Group's portfolio in Q2 2022, its #10 holding.
  • Swarthmore Group first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 26 quarters since.
  • Swarthmore Group's Thermo Fisher Scientific position peaked at $23.6M in Q1 2016.
  • 2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Swarthmore Group's 13F filing for Q2 2022, filed 20 Jul 2022.